The stock of BIOLASE Inc. (BIOL) is trading down-7.00% to $1.4000. It has been trading 14.75% below its three-month high price recently. Another look at the chart shows it trading +395.08% above its three-month low. BIOL is trading -14.75% below its 52-week high and 548.66% above its 52-week low price based on a more comprehensive view.
Get the hottest stocks to trade every day before the market opens 100% free. Click here now.
Recent Update
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
For its fourth quarter ended December 31, BIOLASE, Inc. (NASDAQ: BIOL) reported unaudited preliminary revenue results. It also announced that it currently has about $25 million in cash and can execute its revenue growth strategy with that cash on hand.
Read More
Earnings Highlights:
Sales are expected to reach between $8.2 million and $8.6 million, representing a sequential growth rate of 26-31%. Despite COVID-19 headwinds, U.S. revenue exceeded the previous-year fourth quarter. The number of new users continued its upward trend. Over 40% of sales came from a specialist, a significant increase compared to prior periods. In the US, Waterlase iPlus’s ASPs have increased by 22% compared to the previous year. In the fourth quarter, BIOLASE technology was acquired by four different DSOs.
Company management expects to provide its final financial results for its fourth quarter and full-year 2020 in March.
Get the hottest stocks to trade every day before the market opens 100% free. Click here now.
Institutional Ownership
Suppose we take a glance at the Ownership summary of BIOLASE Inc.’s stock. With 5.17 million shares, Oracle Investment Management, Inc. was the top institutional holder of BIOLASE Inc. (BIOL). With 2.68 million shares, Archon Capital Management LLC is the next largest fund holder of this company’s stock. Perkins Capital Management, Inc. has 1.32 million shares and is ranked third.
